Correspondence 0001104659-22-123288 from Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc.
Date: Nov. 30, 2022 · CIK: 0001279704 · Accession: 0001104659-22-123288
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-268554
Letter
CELLECTAR BIOSCIENCES, INC.
100 Campus Drive
Florham Park, New Jersey 07932
November 30, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jason Drory
Re: Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed November 23, 2022
File No. 333-268554
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-268554), be accelerated so that the Registration Statement will become effective at 5:00 p.m. on December 2, 2022, or as soon as practicable thereafter.
The cooperation of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact Asher M. Rubin (410-559-2881 or arubin@sidley.com) or Istvan A. Hajdu (212-839-5651 or ihajdu@sidley.com). Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
CELLECTAR BIOSCIENCES, INC.
100 Campus Drive
Florham Park, New Jersey 07932
November 30, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jason Drory
Re:
Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed November 23, 2022
File No. 333-268554
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act
of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective
date of the Company’s Registration Statement on Form S-1 (Registration No. 333-268554), be accelerated so that the Registration
Statement will become effective at 5:00 p.m. on December 2, 2022, or as soon as practicable thereafter.
The cooperation
of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact Asher M. Rubin (410-559-2881 or arubin@sidley.com)
or Istvan A. Hajdu (212-839-5651 or ihajdu@sidley.com). Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
By:
/s/ Chad J. Kolean
Chad J. Kolean, Chief Financial Officer
cc:
James V. Caruso
Asher M. Rubin
Istvan A. Hajdu